U.S. market Closed. Opens in 11 hours 23 minutes

TCBP | TC Biopharm (Holdings) Plc Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
RevenueN/A3.84M1.98M1.98M3.43M
Cost of RevenueN/AN/AN/AN/AN/A
Gross ProfitN/A3.84M1.98M1.98M3.43M
Operating Expenses8.81M15.77M9.26M8.32M10.07M
Selling, General & Admin8.76M8.32M3.11M2.21M3.01M
Research & Development9.91M7.45M6.16M6.68M8.61M
Other Operating Expenses6.47M-140.34K-6.38K-569.20K-1.56M
Operating Income-18.15M-12.06M-7.28M-6.34M-6.62M
Other Expenses / Income9.23M8.95M-7.70M-292.06K-275.41K
Before Tax Income-8.92M-3.11M-14.98M-6.63M-6.89M
Income Tax Expenses1.39M-1.72M-1.41M-1.17M-826.07K
Net Income-7.53M-1.39M-13.58M-5.46M-6.07M
Interest Expenses-83.03K6.99M3.44M292.06K275.41K
Basic Shares Outstanding308.92K34.36K19.53K18.92K17.92K
Diluted Shares Outstanding308.92K34.36K19.53K18.92K17.92K
EBITDA-17.35M-11.09M-6.26M-5.26M-5.71M
EBITDA Margin0.00%-288.54%-316.15%-265.97%-166.75%
EBIT-6.23M3.88M-11.54M-6.34M-6.62M
EBIT Margin0.00%101.05%-583.47%-320.31%-193.14%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙